...
search icon
agen-img

Agenus Inc, Common Stock

AGEN

NAQ

$3.57

-$0.19

(-5.05%)

Industry: Biotechnology Sector: Health Care

Price Chart

Key Metrics

Expense Ratio info-icon
The expense ratio is how much you pay a mutual fund or ETF per year, expressed as a percent of your investments. It is a measure of the fund's operating costs relative to assets.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
372.62K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.39
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$2.5 L
$19.69 H
$3.57

About Agenus Inc, Common Stock

Agenus Inc., a clinical-stage biotechnology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops QS-21 Stimulon adjuvant, a saponin-based vaccine adjuvant. The company also develops Balstilimab, an anti-PD-1 antagonist that has completed Phase II clinical trial to treat second line cervical cancer; AGEN1181, an antigen 4 (CTLA-4) blocking antibody that is in Phase 2 clinical trial for the treatment of pancreatic cancer and and melanoma; AGEN2373, a CD137 monospecific antibody that is in Phase 1b clinical trial; AGEN1423, a CD73/TGFß TRAP antibody; AGEN1571, an ILT2 monospecific antibody that is in Phase 1 clinical trial; and BMS-986442, a TIGIT bispecific antibodies. In addition, it develops INCAGN1876, a GITR agonist; INCAGN2390, a TIM-3 monospecific antibody; INCAGN2385, a LAG-3 monospecific antibody; MK-4830, a monospecific antibody targeting ILT4 that is in Phase 2 clinical trial; UGN-301, a zalifrelimab intravesical solution for the treatment of cancers of the urinary tract that is in a Phase 1 clinical trial; and AGEN1884, a first-generation anti-CTLA-4 monospecific antibody. The company operates under Agenus, MiNK, Prophage, Retrocyte Display, and Stimulon trademarks. It has collaborations with Bristol-Myers Squibb Company, Betta Pharmaceuticals Co., Ltd., Incyte Corporation, Merck Sharpe & Dohme, and Gilead Sciences, Inc. The company was formerly known as Antigenics Inc. and changed its name to Agenus Inc. in January 2011. Agenus Inc. was founded in 1994 and is headquartered in Lexington, Massachusetts. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameAGENS&P500
1-Week Return2.59%2.05%
1-Month Return29.82%1.43%
3-Month Return-19.05%5.3%
6-Month Return-41.76%12.75%
1-Year Return-69.56%25.72%
3-Year Return-93.24%38.66%
5-Year Return-95.19%85.64%
10-Year Return-96.54%197.6%

Sector Breakdown

Sector Weight
Health Care
100.00%

FAQs

What is Agenus Inc (AGEN) ETF share price today?

Agenus Inc (AGEN) share price today is $3.57.

Can Indians buy Agenus Inc shares?

Yes, Indians can buy shares of Agenus Inc (AGEN) on Vested. To buy AGEN from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.

Can Fractional shares of Agenus Inc be purchased?

Yes, you can purchase fractional shares of Agenus Inc (AGEN) on Vested. You can start investing in Agenus Inc (AGEN) with a minimum investment of $1.

How to invest in Agenus Inc shares from India?
  • Click on Sign Up or Invest in AGEN ETF at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Agenus Inc shares
What is Agenus Inc's 52-week high and low ETF share price?

The 52-week high price of Agenus Inc (AGEN) is $19.69. The 52-week low price of Agenus Inc (AGEN) is $2.5.

What is Agenus Inc's ticker or symbol?

The stock symbol (or ticker) of Agenus Inc is AGEN.

Can I set up automatic investments (SIP) in Agenus Inc shares?

Yes, you can setup SIP in Agenus Inc shares. Follow the below steps to create the SIP:

  • Sign up on Vested and complete your KYC for US Stocks
  • Transfer funds to your US Stocks account
  • Navigate to AGEN ticker page and set up your recurring investment
What is the historical performance of Agenus Inc ETF?

Here is the historical performance of AGEN on the Vested app.

  • 1-Year Return: -69.56%
  • 3-Year Return: -93.24%
  • 5-Year Return: -95.19%

You can also access the top holdings, the expense ratio, and the sector breakdown for Agenus Inc on Vested.

What is the expense ratio of Agenus Inc?

The expense ratio of Agenus Inc (AGEN) is .

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top